In Review: PCMA and member company representatives have been meeting with Business & Profession Committee members and Senate Health Committee members ahead of this Monday’s, April 15 hearing in B&P on SB 966 (Board of Pharmacy licensing and regulation, ban on spread pricing, AWP, AWSP, delinking, private right of action).
Up Next: PCMA will begin a grassroots and digital ad campaign against SB 966 this week.
If you have any questions, please contact Bill Head at bhead@pcmanet.org.
